New Mexico Register / Volume XXX,
Issue 12 / June 25, 2019
NOTICE OF PUBLIC RULE HEARING
The
New Mexico Medical Board will convene a regular Board Meeting on Thursday,
August 8, 2019 at 8:30 a.m. and Friday, August 9, 2019 at 8:30 a.m., and
conduct a Public Rule Hearing on Friday, August 9, 2019 at 10:20 a.m. at the
New Mexico Medical Board office conference room, located at 2055 South Pacheco
St., Bldg. 400, Santa Fe, NM 87505. The Board will reconvene after the Hearing to
take action on the proposed rule amendments.
The Board may enter into Executive Session during the meeting to discuss
licensing or limited personnel issues.
The
purpose of the Rule Hearing is to consider repealing and replacing 16.10.16
NMAC (Administering, Prescribing, and Distribution of Medications). A copy of the proposed amended rule is
available upon request from the Board office at 2055 South Pacheco Street,
Bldg. 400, Santa Fe, NM 87505, by phone (505) 476-7220, or on the Board’s website
at www.nmmb.state.nm.us.
The
hearing will be conducted in accordance with the Medical Practice Act, Section
61-6-5. B NMSA 1978, the Uniform Licensing Act Section 61-1-1 through 61-1-31
NMSA 1978, the State Rules Act, Section 14-4-5.3 NMSA 1978 and other applicable
procedures.
All
interested persons will be given reasonable opportunity at the hearing to
submit relevant evidence, data, views or arguments orally or in writing. The New Mexico Medical Board will consider
all written comment on the proposed repeal and replacement of 16.10.16 NMAC
that is submitted to the Board no later than 5:00 p.m. Monday, August 5,
2019. Comment must be sent to the New
Mexico Medical Board, Attn: Sondra
Frank, Esq., Executive Director, 2055 South Pacheco Street, Bldg. 400, Santa Fe, NM 87505.
All public comments may be received via mail, electronic mail or fax and
will posted the Board’s website at www.nmmb.state.nm.us within three days of
receipt by the Board. All public
comments will be made part of the official rule hearing record.
If
you are an individual with a disability who is in need of a reader, amplifier,
qualified sign language interpreter, or any other form of auxiliary aid or
service in order to attend or participate in the meeting or rule hearing,
please contact Amanda Quintana at 505-476-7230 or AmandaL.Quintana@state.nm.us
prior to the meeting. Public documents,
including the agenda and minutes, can be provided in various accessible
formats. Please contact the Executive
director if a summary or other type of accessible format is needed.
NOTICE OF RULEMAKING
The
New Mexico Medical Board may consider the following items of rulemaking at the
meeting:
Repeal
16.10.16
NMAC Administering,
Prescribing and Distribution of Medications
Replacement
16.10.16
NMAC Administering,
Prescribing and Distribution of Medications
16.10.16 NMAC
Administering, Prescribing and Distribution of Medications.
SYNOPSIS:
The proposed replacement of 16.10.16
updates the intent of part 16 regarding the administering, prescribing and
distribution of medications by physician assistants. The statutory authority for the New Mexico
Medical Board’s promulgation of this rule is found in the Medical Practice Act
(Sections 66-6-1 to -35 NMSA 1978).
The purpose of amending the Part 16 is to
conform the regulations to House Bill 215 2017 statutory amendments. Amongst
other things, the PA statutory amendment added “collaboration” as a possible
status for PAs and added distribution to PA prescribing abilities. The regulation changes are also necessary
because the current rule on PA prescribing reflects requirement which have not
been statutorily required for many years, including a formulary, direct
physician oversight and limits on prescribing.
Specifically, any reference to a formulary is
deleted; requirements for physician assistant prescription pads is deleted; and
limitations to prescribing by physician assistants is added.